Showing results (261-270 of 335) with videos related to
Sort By:
Pageof 34
Oncotarget|August 22, 2020
Correction: Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5Waseem Al-Jameel, Xiaojun Gou, Shiva S Forootan, et al.Oncotarget|April 19, 2017
Inhibitor SBFI26 suppresses the malignant progression of castration-resistant PC3-M cells by competitively binding to oncogenic FABP5Waseem Al-Jameel, Xiaojun Gou, Shiva S Forootan, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|September 3, 2004
Brain metastases from breast cancer: identification of a high-risk groupA J Evans, J J James, E J Cornford, et al.Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 22, 2023
ESTRO-ACROP recommendations for evidence-based use of androgen deprivation therapy in combination with external-beam radiotherapy in prostate cancerNina-Sophie Schmidt-Hegemann, Constantinos Zamboglou, Malcolm Mason, et al.Clinical Radiology|November 24, 2004
Patterns of metastatic breast carcinoma: influence of tumour histological gradeG J R Porter, A J Evans, S E Pinder, et al.European Urology|January 30, 2020
European Association of Urology Guidelines Office: How We Ensure Transparent Conflict of Interest Disclosure and ManagementEmma Jane Smith, Karin Plass, Julie Darraugh, et al.BMC Health Services Research|May 31, 2011
Integrating telecare for chronic disease management in the community: what needs to be done?Carl R May, Tracy L Finch, James Cornford, et al.Clinical Oncology (Royal College of Radiologists (Great Britain))|April 13, 2004
Metastatic carcinoma of the breast with tubular features: differences compared with metastatic ductal carcinoma of no specific typeL J Hamilton, A J Evans, S E Pinder, et al.British Journal of Cancer|October 2, 2003
Diagnosis of axillary nodal metastases by ultrasound-guided core biopsy in primary operable breast cancerA Damera, A J Evans, E J Cornford, et al.European Urology|November 7, 2017
Updated Guidelines for Metastatic Hormone-sensitive Prostate Cancer: Abiraterone Acetate Combined with Castration Is Another StandardNicolas Mottet, Maria De Santis, Erik Briers, et al.Pageof 34